Profit came in at 9.12 billion rupees ($139.48 million) in the quarter ended Sept. 30, compared with 22.35 billion rupees a year ago, the company said.
India`s largest drugmaker, Sun Pharmaceutical Industries Ltd, posted a 59 percent plunge in second-quarter profit on Tuesday, but beat estimates.
Profit came in at 9.12 billion rupees ($139.48 million) in the quarter ended Sept. 30, compared with 22.35 billion rupees a year ago, the company said.
Analysts on average had expected a profit of 8.27 billion rupees, according to Thomson Reuters data.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.